Atrium Medical Corporation, a subsidiary of Getinge, divests its biosurgery business to HJ Capital 1, the parent company of SeCQure Surgical Corporation
Atrium Medical Corporation, a subsidiary of Getinge, has signed an agreement to divest its biosurgery business to HJ Capital 1, the parent company of SeCQure Surgical Corporation, a global medical device company. The deal is expected to close in the fourth quarter of this year subject to receipt of customary regulatory approvals and satisfaction of other customary closing conditions. Sales in 2017 relating to the biosurgery business amounted to approximately SEK 128 M. The divestment will have no material financial impact on results or financial position.The biosurgery business was added to